The jury found that Merck did not fail to warn consumers about the safety of Vioxx, was not guilty of fraud, did not misrepresent the cardiovascular risks of Vioxx while marketing it to physicians, and did not conceal information about the drug.
“Merck is satisfied with the jury verdict,” said Kenneth Frazier, senior vice president and general counsel for Merck. “There will be other Vioxx trials and we will vigorously defend them one by one over the coming years.”
It’s a “Win” in that Merck isn’t out millions, just several hundreds of thousands for the defense. We should start a pool for the date the last filed case is settled or dismissed. I’m guessing May 2011.